Practical Considerations and Rationale for Glucagon-Like Peptide-1 Receptor Agonist Plus Sodium-Dependent Glucose Cotransporter-2 Inhibitor Combination Therapy in Type 2 Diabetes

Publication date: April 2021Source: Canadian Journal of Diabetes, Volume 45, Issue 3Author(s): Ronald M. Goldenberg, Vineeta Ahooja, Kristin K. Clemens, Jeremy D. Gilbert, Megha Poddar, Subodh Verma
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research